Ratifi English Iniciar sesión
Ratifi

Proyectos federales de Congress.gov. Proyectos estatales de Open States.

HB 2747Sesión 2025-2026

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for schedules of controlled substances.

Printer's No. PN3835

See other bills
under the
same topic PRINTER'S NO. 3835 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE BILL No.2747 Session of 2026 INTRODUCED BY HEFFLEY, KUZMA AND MOUL, AUGUST 24, 2026 REFERRED TO COMMITTEE ON JUDICIARY, AUGUST 25, 2026 AN ACTAmending the act of April 14, 1972 (P.L.233, No.64), entitled "An act relating to the manufacture, sale and possession of controlled substances, other drugs, devices and cosmetics; conferring powers on the courts and the secretary and Department of Health, and a newly created Pennsylvania Drug, Device and Cosmetic Board; establishing schedules of controlled substances; providing penalties; requiring registration of persons engaged in the drug trade and for the revocation or suspension of certain licenses and registrations; and repealing an act," further providing for schedules of controlled substances.The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows:Section 1. Section 4(1) of the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, is amended by adding a subclause to read:Section 4. Schedules of Controlled Substances.--The following schedules include the controlled substances listed or to be listed by whatever official name, common or usual name, chemical name, or trade name designated.(1) Schedule I--In determining that a substance comes within this schedule, the secretary shall find: a high potential for 1234567891011121314151617181920212223 abuse, no currently accepted medical use in the United States, and a lack of accepted safety for use under medical supervision. The following controlled substances are included in this schedule:* * *(ix) Any of the following synthetic benzimidazole-opioid (Nitazenes) substances, including their isomers, esters, ethers, salts, and salts of isomers, esters and ethers whenever the existence of the isomers, esters, ethers and salts is possible:1. 2-(2-(4-butoxybenzyl)-5-nitro-1Hbenzimidazol-1-yl)-N,N-diethylethan-1-amine (butonitazene).2. 2-(2-(4-ethoxybenzyl)-1Hbenzimidazol-1-yl)-N,Ndiethylethan-1-amine (etodesnitazene; etazene).3. N,N-diethyl-2-(2-(4-fluorobenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) (flunitazene).4. N,N-diethyl-2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine (metodesnitazene).5. N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H benzimidazol-1-yl)ethan-1-amine (metonitazene).6. 2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1Hbenzimidazole (N-pyrrolidino etonitazene; etonitazepyne).7. N,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine (protonitazene).8. N,N-diethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine (isotonitazene).* * *Section 2. This act shall take effect in 60 days.20260HB2747PN3835 - 2 - 123456789101112131415161718192021222324252627

Texto oficial de la Legislatura de Pennsylvania. El formato se adaptó para leerlo en Ratifi.